Legend Biotech Corp - ADR

NASDAQ:LEGN   3:59:43 PM EDT
28.87
+0.73 (+2.59%)
Earnings Announcements

Legend Biotech Reports Third Quarter 2020 Financial Results

Published: 11/16/2020 12:51 GMT
(LEGN) - Legend Biotech Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.25.
Q3 Revenue $11.7 Million Versus $17.7 Million.
Q3 Earnings per Share Estimate $-0.31 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $13 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.